BD, Lilly To Continue Canadian Distribution Of Latitude
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson will discontinue U.S. sales of its BD Latitude diabetes management system, citing insufficient market potential for the insulin delivery pen and accompanying pen needles